XBiotech Inc logo

XBiotech Inc

$ 3.70 -0.02 (-0.54%) 12:33 PM EST
P/E:
At Loss
P/B:
0.44
Market Cap:
$ 112.63M
Enterprise V:
$ -112.56M
Volume:
8.98K
Avg Vol (2M):
54.71K
Also Trade In:
Volume:
8.98K
Market Cap $:
112.63M
PE Ratio:
At Loss
Avg Vol (2-Month):
54.71K
Enterprise Value $:
-112.56M
PB Ratio:
0.44
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.96
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.97
Distress
Grey
Safe
Beneish M-Score -1.79
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -13
3-Year EPS without NRI Growth Rate 0.6
3-Year Book Growth Rate 97.3
Name Current Vs Industry Vs History
5-Day RSI 20.9
9-Day RSI 25.64
14-Day RSI 28.08
6-1 Month Momentum % -50.22
12-1 Month Momentum % -68.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 28.99
Quick Ratio 28.99
Cash Ratio 27.42
Days Sales Outstanding 18.64
Days Payable 236.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 5.4

Financials (Next Earnings Date:2022-11-09 Est.)

XBIT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:XBIT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 11.049
EPS (TTM) ($) -0.88
Beta 1.69
Volatility % 38.6
14-Day RSI 28.08
14-Day ATR ($) 0.199924
20-Day SMA ($) 4.0455
12-1 Month Momentum % -68.27
52-Week Range ($) 3.7 - 16.47
Shares Outstanding (Mil) 30.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

XBiotech Inc Filings

Document Form Filing Date
No Filing Data

XBiotech Inc Analysis

Share your research

Headlines

See More
No news.